Search results
Results from the WOW.Com Content Network
However, surfactant decreases the alveolar surface tension, as seen in cases of premature infants with infant respiratory distress syndrome. The normal surface tension for water is 70 dyn/cm (70 mN/m) and in the lungs, it is 25 dyn/cm (25 mN/m); however, at the end of the expiration, compressed surfactant phospholipid molecules decrease the ...
Insufficient surfactant (e.g. respiratory distress syndrome in pre-term babies) . Disorders of the respiratory system are usually treated by a pulmonologist and respiratory therapist. Where there is an inability to breathe or insufficiency in breathing, a medical ventilator may be used.
In respiratory distress syndrome or RDS, surfactant replacement therapy helps patients have normal respiration by using pharmaceutical forms of the surfactants. One example of a pharmaceutical pulmonary surfactant is Survanta ( beractant ) or its generic form Beraksurf, produced by Abbvie and Tekzima respectively.
But two factors prevent the lungs from collapsing: surfactant and the intrapleural pressure. Surfactant is a surface-active lipoprotein complex formed by type II alveolar cells. The proteins and lipids that comprise surfactant have both a hydrophilic region and a hydrophobic region. By absorbing to the air-water interface of alveoli with the ...
Insufficient surfactant in the alveoli is one of the causes that can contribute to atelectasis (collapse of part or all of the lung). Without pulmonary surfactant, atelectasis is a certainty. [26] The severe condition of acute respiratory distress syndrome (ARDS) is caused by a deficiency or dysfunction of surfactant. [27]
Surfactant homeostasis is critical for breathing (and thus survival) in the prematurely born infant, but also for maintaining lung health, and normal lung function throughout life. Changes in the amount or composition of surfactant can alter its function and are associated with respiratory diseases. [10] [11] [12] [13]
Pulmonary surfactant is used as a medication to treat and prevent respiratory distress syndrome in newborn babies. [1] Prevention is generally done in babies born at a gestational age of less than 32 weeks. [1] It is given by the endotracheal tube. [1] Onset of effects is rapid. [2] A number of doses may be needed. [2]
Lung compliance is an important measurement in respiratory physiology. [2] [3] Decreased pulmonary compliance may be associated with fibrosis. Increased pulmonary compliance may be associated with COPD and emphysema due to loss of alveolar and elastic tissue. Pulmonary surfactant increases